SALIOGEN

SalioGen Therapeutics is a next-generation genetic medicine company. Every day, we rely on our core values and expertise to guide our strategies and challenge assumptions, bringing us closer to our goals for patients... Our lead programs in Stargardt's disease and cystic fibrosis have the potential to benefit patients in ways that have remained out of reach - until now. Developing our gene coding technology for a wide range of diseases is also underway.

Also known as: SalioGen Therapeutics, SalioGen Therapeutics, Inc.

Primary location: Lexington United States